Non-network financial disclosure/certification form.
AIDS clinical trials group network IND study financial disclosure form. .zip file includes ACTG Network IND Study Financial Disclosure Form (PDF) ACTG Network IND Study Financial Disclosure Form Template (PDF) ACTG Network IND Study Financial Disclosure Form Fillable (PDF)
DIFLUCAN (fluconazole), the first of a new subclass of synthetic triazole antifungal agents, is available as tablets for oral administration, as a powder for oral suspension.
Guidelines for Electronic Submissions Via Email-EPR Guidelines
The Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events, Version 2.0 contains a number of changes detailed below when compared with the Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events, Version 1.0 – December 2004 (…
.zip files contains Presentation to HPTN/IMPAACT Annual Meeting on Expedited Reporting to DAIDS and DAERS refresher course Expedited reporting via DAERS - Case Study
.zip file contains: Presentation to HVTN Annual Meeting on Expedited Reporting to DAIDS and DAERS refresher course; Expedited reporting via DAERS - Case Study
Guidance and requirements for daids-supported research involving recombinant DNA.
.zip files contains: Safety training presentation on expedited reporting to DAIDS and a refresher on DAERS Case study handout Meeting for HPTN and IMPAACT networks was held June 2016.
List of IND protocols having CRF/Pharmacy records that will not be stored by DAIDS.
Instructions for the transfer of case report forms, (CRF) and pharmacy records to the DAIDS regulatory support center, (DAIDS RSC).
Informed Consent documents are in the process of being updated to be compliant with the revised Common Rule.